Vasoactive intestinal peptide as a new drug for treatment of primary pulmonary hypertension

Primary pulmonary hypertension is a fatal disease causing progressive right heart failure within 3 years after diagnosis. We describe a new concept for treatment of the disease using vasoactive intestinal peptide, a neuropeptide primarily functioning as a neurotransmitter that acts as a potent syste...

Celý popis

Uloženo v:
Podrobná bibliografie
Hlavní autoři: Petkov, Ventzislav, Mosgoeller, Wilhelm, Ziesche, Rolf, Raderer, Markus, Stiebellehner, Leopold, Vonbank, Karin, Funk, Georg-Christian, Hamilton, Gerhard, Novotny, Clemens, Burian, Bernhard, Block, Lutz-Henning
Médium: Článek
Jazyk:en
Vydáno: American Society for Clinical Investigation 2003
Témata:
Article
On-line přístup:https://ncbi.nlm.nih.gov/pmc/articles/PMC154449/
https://ncbi.nlm.nih.gov/pubmed/12727925
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1172/JCI200317500
Tagy: Přidat tag
Žádné tagy, Buďte první, kdo otaguje tento záznam!

Internet

https://ncbi.nlm.nih.gov/pmc/articles/PMC154449/
https://ncbi.nlm.nih.gov/pubmed/12727925
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1172/JCI200317500

Podobné jednotky